The Effect of Empagliflozin Versus Metformin on Hormonal, Metabolic and Cardiovascular Risk Factors in Patients With Polycystic Ovary Syndrome (PCOS) - a Randomised Open-label Parallel Study.
Phase of Trial: Phase II/III
Latest Information Update: 06 Oct 2017
At a glance
- Drugs Empagliflozin (Primary) ; Metformin
- Indications Polycystic ovary syndrome
- Focus Therapeutic Use
- 30 Sep 2017 Status changed from not yet recruiting to recruiting.
- 22 Jul 2017 Planned initiation date changed from 1 Jun 2017 to 1 Aug 2017.
- 23 Mar 2017 Planned End Date changed from 1 Mar 2018 to 1 May 2018.